REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Samsung Biologics Co., Ltd. (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Samsung Biologics Co., Ltd. Profile Updated: March 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Samsung Biologics Co., Ltd. is an enterprise based in South Korea. Its main office is in Incheon. It operates in the Pharmaceutical Preparation Manufacturing industry. It was incorporated on April 22, 2011. 5,455 (2025) employees currently work for Samsung Biologics Co., Ltd.. In its most recent financial highlights, the company reported a net sales revenue increase of 0.21% in 2025. Its’ total assets recorded a negative growth of 36.2%. The net profit margin of Samsung Biologics Co., Ltd. increased by 15.34% in 2025.

Headquarters
300 Songdo Bio Way (Daero), Yeonsu-Gu
Incheon; Incheon;

Contact Details: Purchase the Samsung Biologics Co., Ltd. report to view the information.

Website: http://www.samsungbiologics.com

Basic Information
Total Employees:
Purchase the Samsung Biologics Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Samsung Biologics Co., Ltd. report to view the information.
Registered Capital:
Purchase the Samsung Biologics Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Samsung Biologics Co., Ltd. report to view the information.
Incorporation Date:
April 22, 2011
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
43.4%
Purchase this report to view the information.
31.5%
Purchase this report to view the information.
0.1%
Purchase this report to view the information.
Subsidiaries
Samsung Biologics America, Inc. (United States)
Company Performance
Financial values in the chart are available after Samsung Biologics Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
0.21%▲
Total Operating Revenue
1.15%▲
Operating Profit
67.75%▲
EBITDA
42.89%▲
Net Profit/Loss for the Period
64.71%▲
Total Assets
-36.2%▼
Total Equity
-31.67%▼
Operating Profit Margin
18.68%▲
Net Profit Margin
15.34%▲
Return on Equity (ROE)
14.02%▲
Debt / Equity
-1.19%▼
Quick Ratio
0.2%▲
Cash Ratio
-0.04%▼

Similar companies

Green Cross Holdings Corporation
 
Yuhan Corporation
Chong Kun Dang Pharmaceutical Corp.
 
Daewoong Pharmaceutical Co.,Ltd.
Dong-A Socio Holdings Co.,Ltd.
 
Daewoong Co.,Ltd.
Chongkundang Holdings Corp.
 
Hk Inno.N Corporation
Boryung Corporation
 
Jeil Pharma Holdings Inc.

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo